Earth Science Tech, Inc. Expands its Full Spectrum Cannabinoid (CBD) Chocolate Line with Three New Unique Products
DORAL, Florida, June 29, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabinoids (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and development, is expanding its full spectrum cannabinoid (CBD) chocolate line with three unique new products.
Hinted in Wednesday's announcement, the Company and its joint venture partner, Karmavore Superfoods, have formulated three unique, new full spectrum cannabinoid chocolate products. The new products are formulated with the Company’s known and effective High Grade Full Spectrum Cannabinoid oil, raw arriba nacional cacao, as well as other natural organic superfood ingredients. The new products include Raw Dark Chocolate Covered Mangoes, Raw Dark Chocolate Coconut Peppermint Cups, and Raw Dark Chocolate Caramelized Quinoa Crunch. With the introduction of these new products, the Company will now have five unique CBD Raw Chocolate flavors.
The Company is currently in production of its new chocolate products and anticipates a successful launching within the 3rd calendar quarter of 2018.
Karmavore Superfood’s founder & CEO, Brian Miller states, “We’re so happy to be working with Earth Science Tech, making the healthiest, best tasting and most effective CBD edibles available. We’re very excited to expand our already popular CBD chocolate edible line with the addition of three great new products. Customers in our test markets have been loving them, and I anticipate our edible line will soon become one of the most popular in the CBD market”.
The Company’s Chief Sales Officer, Jill Buzan, comments, “I am excited about having the three new flavors to offer to the market. Karmavore uses the highest quality organic superfoods and combined with our high grade hemp oil, we are offering consumers an extremely pure, clean and nutritious edible line!”
Nickolas S. Tabraue, the Company’s President, Director, and Chairman ends with, “Our joint venture with Karmavore Superfoods has been a true blessing. Brian Miller has been amazing to work with and, thanks to his innovative chocolate formulations infused with our full spectrum cannabinoids, we continue to offer a great-tasting, truly matchless CBD edible product line to our direct customers and wholesale accounts.”
The Company plans to share further updates on the launch date of the three new chocolate products, research and development, Form 10 approval, and medical device updates as each progresses.
About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma; in addition to studies through DV Biologics that prove the Company’s CBD oil formulation t lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.com
ETST currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
Earth Science Pharmaceutical
Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharma, Inc. ("ESP"), which is committed to the development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP's CEO and chief science officer, Dr. Michel Aubé, is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
To learn more please visit: www.EarthSciencePharmaceutical.com
Cannabis Therapeutics
Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs.
To learn more please visit: www.CannabisThera.com
KannaBidioiD
KannaBidioid, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioiD, Inc. (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
To learn more please visit: www.KannaBidioiDInc.com
Earth Science Foundation, Inc.
Earth Science Foundation, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Earth Science Foundation, Inc. ("ESF"), is in the process of becoming a nonprofit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech, Inc's effective CBD products to those in need.
To learn more please visit: www.ETSTFoundtion.org
About Karmavore Superfoods
Born as a passion project by founder Brian Miller, a world renowned yoga teacher, health enthusiast and entrepreneur. Karmavore Superfoods is a superfood based health food company producing premium quality packaged snack foods using only the healthiest, most nutritionally dense ingredients available. Their mission is to make the tastiest and healthiest snacks possible. Their products are formulated by specifically choosing each ingredient based not only on its taste profile, but on its nutritional profile and how it interacts with our system. All of the products are organic, vegan, gluten free, low in sugar and refined sugar free. Not only do the products taste amazing, they leave you feeling great as well.
To learn more please visit: www.karmavoresuperfoods.com
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Investor Relations Contact: Dave Demarest 305.546.7640 Office Company Contact: www.EarthScienceTech.com Nickolas S. Tabraue President, Director, & Chairman 305.615.2118
© 2018 GlobeNewswire, Inc. All Rights Reserved.
Moderna (Nasdaq: MRNA) Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
